SMSPHARMA Stock Overview
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
SMS Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹209.15 |
| 52 Week High | ₹219.40 |
| 52 Week Low | ₹79.40 |
| Beta | 1.18 |
| 1 Month Change | 14.38% |
| 3 Month Change | 67.32% |
| 1 Year Change | 148.84% |
| 3 Year Change | 36.88% |
| 5 Year Change | 244.00% |
| Change since IPO | 482.19% |
Recent News & Updates
Recent updates
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up
Feb 29
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment
Sep 24SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30
Sep 11SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 28SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet
Jun 07Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why
Sep 23SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30
Sep 15SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30
Sep 01SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30
Aug 18We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt
Mar 22SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality
Jun 03Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?
Mar 08What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?
Feb 22The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It
Feb 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 18
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden
Dec 09Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?
Nov 18The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It
Oct 28What Kind Of Shareholders Hold The Majority In SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Shares?
Oct 08Are Dividend Investors Getting More Than They Bargained For With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Dividend?
Sep 17SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Aug 26SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Could Signal Some Risk
Aug 08SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Business Is Trailing The Market But Its Shares Aren't
Aug 08SMS Pharmaceuticals Limited (NSE:SMSPHARMA) Looks Just Right
Jul 25SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Price Matching Investor Opinion
Jul 07Shareholder Returns
| SMSPHARMA | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0.02% | -0.1% | 1.8% |
| 1Y | 148.8% | 55.9% | 46.4% |
Return vs Industry: SMSPHARMA exceeded the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: SMSPHARMA exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| SMSPHARMA volatility | |
|---|---|
| SMSPHARMA Average Weekly Movement | 9.6% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: SMSPHARMA's share price has been volatile over the past 3 months.
Volatility Over Time: SMSPHARMA's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 1,095 | Ramesh Potluri | www.smspharma.com |
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, anti-epileptic, anti-psychotic, anti-inflammatory, anti-fungal, anti-viral, anti-coagulant, and anti-retroviral products. It is also involved in the contract research activities.
SMS Pharmaceuticals Limited Fundamentals Summary
| SMSPHARMA fundamental statistics | |
|---|---|
| Market cap | ₹17.70b |
| Earnings (TTM) | ₹360.58m |
| Revenue (TTM) | ₹6.13b |
49.1x
P/E Ratio2.9x
P/S RatioIs SMSPHARMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMSPHARMA income statement (TTM) | |
|---|---|
| Revenue | ₹6.13b |
| Cost of Revenue | ₹4.22b |
| Gross Profit | ₹1.91b |
| Other Expenses | ₹1.55b |
| Earnings | ₹360.58m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.26 |
| Gross Margin | 31.16% |
| Net Profit Margin | 5.88% |
| Debt/Equity Ratio | 57.8% |
How did SMSPHARMA perform over the long term?
See historical performance and comparison